{"schema_version":"1","generated_at":"2026-11-08T18:06:25.794Z","data_as_of":"2026-11-06","url":"https://www.findmykol.com/kol/jeffrey-mangel","json_url":"https://www.findmykol.com/kol/jeffrey-mangel/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"jeffrey-mangel","name":"Jeffrey Mangel","credential":"MD","title":"Division Director of Urogynecology","specialty":"Gynecologic Oncology","specialty_raw":"Obstetrics & Gynecology","therapeutic_area":"Genitourinary","therapeutic_areas":["Genitourinary","Gynecologic"],"institution":"MetroHealth","institution_url":"https://www.findmykol.com/institution/metrohealth","city":"Cleveland","state":"OH","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1679689913","orcid":"0009-0005-8755-1052","openalex":"A5037038645"},"summary":"Jeffrey Mangel is Division Director of Urogynecology at MetroHealth. OpenAlex indexes 88 publications with 1,321 citations (h-index 17); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.","overview":{"text":"Jeffrey Mangel, MD, is Division Director of Urogynecology at MetroHealth. The public record shows 88 publications with 1,321 citations (h-index 17), centered on Pelvic floor disorders treatments, Urinary Bladder and Prostate Research, Urinary Tract Infections Management. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 13 companies.","bullets":["Most recent indexed publication: 2026 · International urogynecology journal","Top research focus: Pelvic floor disorders treatments","2 registered trials on ClinicalTrials.gov","Open Payments reporting from 13 companies"],"generated_at":"2026-11-07"},"focus":{"indications":[{"label":"Urinary Incontinence","therapeutic_area":"Nephrology","trials":2,"topics":0,"strength":6},{"label":"Urinary Bladder, Overactive","therapeutic_area":"Nephrology","trials":1,"topics":0,"strength":3},{"label":"Prostatic Hyperplasia","therapeutic_area":"Genitourinary","trials":1,"topics":0,"strength":3},{"label":"Hyperplasia","therapeutic_area":"Epidemiology","trials":1,"topics":0,"strength":3},{"label":"Urinary Incontinence, Urge","therapeutic_area":"Nephrology","trials":1,"topics":0,"strength":3},{"label":"Alzheimer's / Dementia","therapeutic_area":"Neurology","trials":0,"topics":0,"strength":1},{"label":"Bladder / Urothelial Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Ovarian / Gynecologic Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Substance Use Disorders","therapeutic_area":"Psychiatry","trials":0,"topics":0,"strength":1}],"research_topics":["Pelvic floor disorders treatments","Urinary Bladder and Prostate Research","Urinary Tract Infections Management","Uterine Myomas and Treatments","Surgical Simulation and Training"],"drugs_studied":{"total":3,"shown":3,"withheld":0,"rows":[{"name":"Myrbetriq","generic":"Mirabegron","trials":0,"payments":12,"publications":1,"mentions":13},{"name":"Botox","generic":"Botulinum toxin type A","trials":0,"payments":2,"publications":0,"mentions":2},{"name":"ORILISSA","trials":0,"payments":1,"publications":0,"mentions":1}]},"works_with":{"total":13,"shown":3,"withheld":10,"rows":[{"name":"Axonics, Inc.","trials":0,"payments":33,"mentions":33},{"name":"Coloplast Corp","trials":0,"payments":32,"mentions":32},{"name":"Medtronic, Inc.","trials":0,"payments":29,"mentions":29}]}},"scholarship":{"works_count":88,"cited_by_count":1321,"h_index":17,"i10_index":21,"pubmed_count":1,"latest_activity_year":2026,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07456865","title":"Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device","phase":"NA","status":"RECRUITING","role":"Investigator","sponsor":"MedtronicNeuro","source_url":"https://clinicaltrials.gov/study/NCT07456865","trial_url":"https://www.findmykol.com/trial/NCT07456865"},{"nct":"NCT07425015","title":"Ambulatory Long Length URodynamics Evaluation","phase":"NA","status":"RECRUITING","role":"Investigator","sponsor":"Bright Uro","source_url":"https://clinicaltrials.gov/study/NCT07425015","trial_url":"https://www.findmykol.com/trial/NCT07425015"}],"source":"trials"},"payments":{"company_count":13,"program_years":{"first":2021,"last":2025},"rows_total":32,"shown":3,"withheld":29,"rows":[{"payer":"COLOPLAST CORP","program_year":2025,"amount_usd":22596,"payment_count":11,"source_url":"https://openpaymentsdata.cms.gov/search?query=1679689913"},{"payer":"Medtronic, Inc.","program_year":2025,"amount_usd":686.35,"payment_count":17,"source_url":"https://openpaymentsdata.cms.gov/search?query=1679689913"},{"payer":"Boston Scientific Corporation","program_year":2025,"amount_usd":270.04,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1679689913"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1679689913","source":"payments"},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":10,"years":{"first":2007,"last":2025},"societies":["AUA"],"shown":3,"withheld":7,"rows":[{"title":"MP30-12 RESULTS OF THE SANS-UUI, PHASE II STUDY: SAFETY OUTCOMES AT 6-MONTHS FOR PATIENTS WITH OAB SYMPTOMS USING NEUSPERA’S ULTRA-MINIATURIZED SYSTEM COMPARED TO THE PUBLISHED STANDARD OF CARE","society":"AUA","meeting":"AUA Annual Meeting","year":2025,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1097/01.ju.0001110076.71872.1a.12","source_url":"https://doi.org/10.1097/01.ju.0001110076.71872.1a.12","status":"verified"},{"title":"MP79-17 LEVEL OF DIFFICULTY AND TRAUMA ASSOCIATED WITH REMOVAL OF THE TINED LEAD FOR SACRAL NEUROMODULATION","society":"AUA","meeting":"AUA Annual Meeting","year":2018,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1016/j.juro.2018.02.2685","source_url":"https://doi.org/10.1016/j.juro.2018.02.2685","status":"verified"},{"title":"MP31-16 CONCOMITANT OVERACTIVE BLADDER MEDICATION USAGE AFTER SACRAL NEUROMODULATION IMPLANT","society":"AUA","meeting":"AUA Annual Meeting","year":2017,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1016/j.juro.2017.02.970","source_url":"https://doi.org/10.1016/j.juro.2017.02.970","status":"verified"}],"source":"congress"},"publications":{"total":1,"shown":1,"withheld":0,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Randomized, Sham-Controlled, Double-Blind Trial of the Intibia System in Urge Urinary Incontinence: Quality-of-Life Outcomes.","year":2026,"journal":"International urogynecology journal","types":["Journal Article","Randomized Controlled Trial","Multicenter Study"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42329399/","status":"verified"}],"most_cited":{"total":88,"shown":5,"withheld":83,"rows":[{"title":"Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6‐months in subjects with mild symptoms of overactive bladder","year":2014,"cited_by_count":213,"type":"article","source_url":"https://doi.org/10.1002/nau.22544"},{"title":"Five-Year Followup Results of a Prospective, Multicenter Study of Patients with Overactive Bladder Treated with Sacral Neuromodulation","year":2017,"cited_by_count":184,"type":"article","source_url":"https://doi.org/10.1016/j.juro.2017.07.010"},{"title":"Three-year Follow-up Results of a Prospective, Multicenter Study in Overactive Bladder Subjects Treated With Sacral Neuromodulation","year":2016,"cited_by_count":130,"type":"article","source_url":"https://doi.org/10.1016/j.urology.2016.04.024"},{"title":"Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder","year":2014,"cited_by_count":98,"type":"article","source_url":"https://doi.org/10.1002/nau.22707"},{"title":"Dorsal genital nerve stimulation for the treatment of overactive bladder symptoms","year":2007,"cited_by_count":87,"type":"article","source_url":"https://doi.org/10.1002/nau.20544"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"David D. Sheyn","coauthored_works":39},{"name":"Sangeeta Tina Mahajan","coauthored_works":32},{"name":"Sherif A. El‐Nashar","coauthored_works":26}],"source":"works"},"presence":{"owned_accounts":{"total":2,"shown":2,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/jeffrey-mangel-md","status":"verified"},{"platform":"researchgate","url":"https://www.researchgate.net/scientific-contributions/Jeffrey-Mangel-2042090618","status":"verified"}]},"mentions":{"total":7,"shown":3,"rows":[{"url":"https://doctor.webmd.com/doctor/jeffrey-mangel-019aea04-92d0-40db-a8bd-c2fcf44b51c3-overview","platform":"other","status":"provisional"},{"url":"https://health.usnews.com/doctors/jeffrey-mangel-511961","platform":"other","status":"provisional"},{"url":"https://ourhealthnetwork.com/doctor/jeffrey-mangel-md-1679689913","platform":"other","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":3,"shown":3,"rows":[{"value":"MD, McGill University Faculty of Medicine (Canada)","source_url":"https://www.metrohealth.org/en/providers/jeffrey-mangel-035907/","status":"verified","collected_at":"2026-11-06"},{"value":"Board certified, American Board of Obstetrics & Gynecology - Obstetrics & Gynecology","source_url":"https://www.metrohealth.org/en/providers/jeffrey-mangel-035907/","status":"verified","collected_at":"2026-11-06"},{"value":"Board certified, American Board of Obstetrics & Gynecology - Female Pelvic Medicine & Reconstructive Surgery","source_url":"https://www.metrohealth.org/en/providers/jeffrey-mangel-035907/","status":"verified","collected_at":"2026-11-06"}]},"secondary_affiliations":{"total":2,"shown":2,"rows":[{"value":"Associate Professor, Case Western Reserve University School of Medicine","source_url":"https://www.metrohealth.org/en/providers/jeffrey-mangel-035907/","status":"verified","collected_at":"2026-11-06"},{"value":"Assistant Professor, Reproductive Biology, Case Western Reserve University","source_url":"https://www.doximity.com/pub/jeffrey-mangel-md","status":"provisional","collected_at":"2026-11-06"}]},"media":{"total":2,"shown":2,"rows":[{"value":"Quoted as Division Director of Urogynecology in MetroHealth patient-education article on pelvic floor health","source_url":"https://www.metrohealth.org/en/besimplywell/content/lets-talk-about-pelvic-floor-health/","status":"verified","collected_at":"2026-11-06"},{"value":"Invited discussant on MDedge OB/GYN coverage of asymptomatic stage 2 pelvic organ prolapse","source_url":"https://mdedge.com/obgyn/article/81603/surgery/asymptomatic-stage-2-pelvic-organ-prolapse-seldom-progresses","status":"provisional","collected_at":"2026-11-06"}]}},"similar":[{"name":"Corrilynn Hileman","slug":"corrilynn-hileman","institution":"MetroHealth","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/corrilynn-hileman","json_url":"https://www.findmykol.com/kol/corrilynn-hileman/profile.json"},{"name":"Jackson Wright","slug":"jackson-wright","institution":"MetroHealth","specialty":"Internal Medicine","url":"https://www.findmykol.com/kol/jackson-wright","json_url":"https://www.findmykol.com/kol/jackson-wright/profile.json"},{"name":"Alfred Connors","slug":"alfred-connors","institution":"MetroHealth","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/alfred-connors","json_url":"https://www.findmykol.com/kol/alfred-connors/profile.json"},{"name":"Tao Cheng","slug":"tao-cheng","institution":"MetroHealth","url":"https://www.findmykol.com/kol/tao-cheng","json_url":"https://www.findmykol.com/kol/tao-cheng/profile.json"},{"name":"Howard Scher","slug":"howard-scher","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/howard-scher","json_url":"https://www.findmykol.com/kol/howard-scher/profile.json"},{"name":"Toni Choueiri","slug":"toni-choueiri","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/toni-choueiri","json_url":"https://www.findmykol.com/kol/toni-choueiri/profile.json"},{"name":"Robert Motzer","slug":"robert-motzer","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/robert-motzer","json_url":"https://www.findmykol.com/kol/robert-motzer/profile.json"},{"name":"Fred Saad","slug":"fred-saad","institution":"Centre hospitalier de l'Université de Montréal (CHUM)","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/fred-saad","json_url":"https://www.findmykol.com/kol/fred-saad/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":29,"congress":7,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-06"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-06"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-11-06"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-06"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-11-06"}},"methodology_url":"https://www.findmykol.com/about#methodology"}